Literature DB >> 24380036

Delayed Diagnosis of Metastatic Ewing Sarcoma Masked by Charcot-Marie-Tooth Disease.

Ines B Menjak1, Abha Gupta2, Michelle N Grinman3.   

Abstract

An 18-year-old male with a history of Charcot-Marie-Tooth disease (CMT) presented with metastatic Ewing sarcoma to the lungs. He had been followed by several healthcare professionals who ascribed his enlarging 23 cm gluteal mass to his CMT. The patient experienced a significant delay in diagnosis, not uncommon in sarcoma. This case explores the various system and cognitive errors that contributed to this delay.

Entities:  

Keywords:  Ewing family of tumors; Ewing sarcoma; cancer care continuum; comorbidity; diagnosis

Year:  2013        PMID： 24380036      PMCID： PMC3869413          DOI： 10.1089/jayao.2013.0009

Source DB:  PubMed          Journal:  J Adolesc Young Adult Oncol        ISSN： 2156-5333            Impact factor:   2.223


  23 in total

1.  Vincristine exacerbates asymptomatic Charcot-Marie-tooth disease with a novel EGR2 mutation.

Authors:  Tomonori Nakamura; Akihiro Hashiguchi; Shinsuke Suzuki; Kimiharu Uozumi; Shoko Tokunaga; Hiroshi Takashima
Journal:  Neurogenetics       Date:  2012-01-25       Impact factor: 2.660

2.  Genetic and clinical aspects of Charcot-Marie-Tooth's disease.

Authors:  H Skre
Journal:  Clin Genet       Date:  1974       Impact factor: 4.438

Review 3.  Reducing diagnostic errors in medicine: what's the goal?

Authors:  Mark Graber; Ruthanna Gordon; Nancy Franklin
Journal:  Acad Med       Date:  2002-10       Impact factor: 6.893

4.  Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the istituto rizzoli.

Authors:  G Bacci; S Ferrari; F Bertoni; D Donati; P Bacchini; A Longhi; A Brach Del Prever; C Forni; S Rimondini
Journal:  J Clin Oncol       Date:  2000-02       Impact factor: 44.544

Review 5.  Update on Charcot-Marie-Tooth disease.

Authors:  Agnes Patzkó; Michael E Shy
Journal:  Curr Neurol Neurosci Rep       Date:  2011-02       Impact factor: 5.081

6.  Soft-tissue sarcoma involving bone or neurovascular structures: MR imaging prognostic factors.

Authors:  D M Panicek; S D Go; J H Healey; D H Leung; M F Brennan; J J Lewis
Journal:  Radiology       Date:  1997-12       Impact factor: 11.105

7.  Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.

Authors:  Holcombe E Grier; Mark D Krailo; Nancy J Tarbell; Michael P Link; Christopher J H Fryer; Douglas J Pritchard; Mark C Gebhardt; Paul S Dickman; Elizabeth J Perlman; Paul A Meyers; Sarah S Donaldson; Sheila Moore; Aaron R Rausen; Teresa J Vietti; James S Miser
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

8.  Presenting symptoms and treatment delay in osteosarcoma and Ewing's sarcoma.

Authors:  O Sneppen; L M Hansen
Journal:  Acta Radiol Oncol       Date:  1984

9.  Bone tumors in children. Differential characteristics and treatment.

Authors:  M C Gebhardt
Journal:  Postgrad Med       Date:  1984-09-15       Impact factor: 3.840

10.  Vincristine treatment triggering the expression of asymptomatic Charcot-Marie-Tooth disease.

Authors:  Y Neumann; A Toren; G Rechavi; B Seifried; N G Shoham; M Mandel; G Kenet; N Sharon; M Sadeh; R Navon
Journal:  Med Pediatr Oncol       Date:  1996-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.